The Macular Pigment Screener (MPS ll) from Elektron Technology is a portable screening device enabling early detection of patients at risk of Age-Related Macular Degeneration (AMD) – the leading cause of vision loss in people over 50.
Latest news: Version 5.2 MPS II software launched
The paper suggests and outlines pragmatic guidelines for a coherent strategy around Prevention and Management of AMD.
|In 2011 as many as 11 million Americans had some form of macular degeneration, including both early and later stages of the wet and dry forms3. As the world population ages the number of people affected by AMD is expected to double within 20 years, creating a ‘Silver Tsunami’. This requires a preventative management strategy given that there is no cure for AMD.|
Low levels of MP are a modifiable risk factor for AMD1 and once detected, need managing through diet, supplementation and lifestyle in order to minimise the risk of early onset AMD2.
Visual Health: Detect and Protect
The Global cost of AMD was $343 billion dollars in 2010 including US$255 billion direct health care costs.4
Early detection of patients at risk of blindness (AMD)
✓ Empowers proactive care management
The world’s first fully portable macular screener
✓ Low cost
1Beatty et al. (1999, 2000, 2001) and Hammond et al. (1998).
2Seddon et all, (1994) JAMA: 272(18), Stringham and Hammond. Optom Vis Sci 85, Richer et al Optometry, Vol 82, No 11